Johan van Beek - Concepedia

Author

Johan van Beek

Also Known As

J Van Beek, J van Beek, J. Beek, J. van Beek, J. van der Beek, JOHAN VAN DER BEEK, JOHAN Van BEEK, Johan Van Beek, Johan van Beek

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Lundbeck (Denmark)Roche (Switzerland)Biogen (Switzerland)University of Toronto University of California San Diego

About

Johan van Beek is an author at Lundbeck (Denmark) specializing in medicine, pharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.6K
2	Health Sciences	2	2	204
3	Social Sciences	2	2	288
4	Allergy	2	2	172
5	Cell Biology	2	2	293

Johan van Beek

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. Jan M. Van Nueten, P A Janssen, Johan van Beek, Journal of Pharmacology and Experimental Therapeutics	1981	524
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial Ludwig Kappos, Hans‐Peter Hartung, Mark S. Freedman, The Lancet Neurology Neurological DisorderPain MedicineMedicineClinical NeurologyNeurological Progress	2014	325
Progressive Degeneration of Human Mesencephalic Neuron-Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway Julie Lotharius, Jeppe Falsig, Johan van Beek, Journal of Neuroscience Progressive DegenerationMixed-lineage Kinase PathwayMedicineApoptosisAutophagy	2005	262
Disruption of Neurogenesis on Gestational Day 17 in the Rat Causes Behavioral Changes Relevant to Positive and Negative Schizophrenia Symptoms and Alters Amphetamine-Induced Dopamine Release in Nucleus Accumbens Peter Flagstad, Arne Mørk, Birte Glenthøj, Neuropsychopharmacology Neurobiological MechanismDevelopmental BiologyGestational Day 17PsychiatryBehavioral Neuroscience	2004	210
Neuroprotective properties of memantine in different <i>in vitro</i> and <i>in vivo</i> models of excitotoxicity Christiane Volbracht, Johan van Beek, Changlian Zhu, European Journal of Neuroscience Neonatal Hypoxia-ischemiaExperimental PharmacologyNeuroinflammationAlzheimer's DiseaseNeuroprotective Properties	2006	173
Reduced Functional Deficits, Neuroinflammation, and Secondary Tissue Damage after Treatment of Stroke by Nonerythropoietic Erythropoietin Derivatives Pia Villa, Johan van Beek, Anna Kirstine Larsen, Journal of Cerebral Blood Flow & Metabolism Cerebrovascular DiseaseFocal Cerebral IschemiaOxidative StressNeuroinflammationInflammation	2006	153
Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study Luciana Midaglia, Patricia Mulero, Xavier Montalbán, Journal of Medical Internet Research	2019	129
Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death Johan van Beek, Olivier Nicole, Carine Ali, Neuroreport ImmunotoxicologyApoptosisImmunologyCell DeathCellular Physiology	2001	109
A smartphone sensor-based digital outcome assessment of multiple sclerosis Xavier Montalbán, Jennifer Graves, Luciana Midaglia, Multiple Sclerosis Journal	2021	104
Nonhematopoietic Erythropoietin Derivatives Prevent Motoneuron Degeneration In Vitro and In Vivo Tiziana Mennini, Massimiliano De Paola, Paolo Bigini, Molecular Medicine	2006	84

Page 1